Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US

Introduction: This study evaluated the cost-effectiveness of atezolizumab + chemotherapy vs. chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC) in the United States (US). Methods: The three health states partitioned survival (PS) model was used over the lifetime....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Public Health
Autors principals: Wang, Yingcheng, Rui, Mingjun, Yang, Lan, Wang, Xintian, Shang, Ye, Ma, Aixia, Li, Hongchao
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Public Health
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8055835/
https://ncbi.nlm.nih.gov/pubmed/33889559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2021.650392
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars